天坛生物：未来天坛昆明投产后，现天坛上海所属24家浆站将转为对天坛昆明供浆

Group 1 - Company TianTan Biological (600161.SH) has 24 plasma stations under its Shanghai subsidiary, with 15 currently operational and 9 under construction, indicating a strong focus on expanding blood source and increasing plasma collection volume [1] - The company plans to transition the 24 plasma stations in Shanghai to supply plasma to the new Kunming facility once it becomes operational [1] - The Kunming facility is expected to officially start production of three major product categories by 2026, with a designed capacity of 1200 tons, raising concerns about the adequacy of plasma collection to meet this capacity [3]